{
    "2020-11-25": [
        [
            {
                "time": "",
                "original_text": "A股为何杀跌？华为罕见发声，发改委也有动作",
                "features": {
                    "keywords": [
                        "A股",
                        "杀跌",
                        "华为",
                        "发改委"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "科技",
                        "政策"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药股还好吗？年底将迎来两件大事 大降价逃不掉",
                "features": {
                    "keywords": [
                        "医药股",
                        "年底",
                        "大降价"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "带量集采、医保目录谈判开启，大降价逃不掉，医药股还好吗？",
                "features": {
                    "keywords": [
                        "带量集采",
                        "医保目录",
                        "谈判",
                        "大降价",
                        "医药股"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "国产品牌出海 高端医疗器械市场争夺战升级",
                "features": {
                    "keywords": [
                        "国产品牌",
                        "出海",
                        "高端医疗器械",
                        "市场争夺"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "【国信医药】全面国际化，迎接“十四五”（2021年度策略）",
                "features": {
                    "keywords": [
                        "国信医药",
                        "国际化",
                        "十四五",
                        "策略"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "【医药】阿斯利康新冠疫苗达到主要功效终点，医药进入配置阶段——医药行业周报——中性",
                "features": {
                    "keywords": [
                        "阿斯利康",
                        "新冠疫苗",
                        "主要功效",
                        "医药行业",
                        "配置阶段"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医用耗材集采风暴压境，下一步将“刮”到骨科眼科类",
                "features": {
                    "keywords": [
                        "医用耗材",
                        "集采",
                        "风暴",
                        "骨科",
                        "眼科"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}